Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 16:00:00 2026-01-23 EST			5-day change	1st Jan Change
68.16 ^USD	-2.14%		-2.57%	+15.90%

01-13	Bio-Techne Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 09:00 AM
01-09	Stephens Adjusts Bio-Techne Price Target to $80 From $70, Maintains Overweight Rating	MT

Transcript : Bio-Techne Corporation Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 03

Published on 06/04/2025 at 05:05 pm EDT - Modified on 06/05/2025 at 05:12 pm EDT

S&P Capital IQ

Presenter Speech
Tycho Peterson (Analysts)

Let's get started. I'm Tycho Peterson from the life science team. It's my pleasure to introduce Bio-Techne.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Bio-Techne Corporation

01-13	Bio-Techne Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 09:00 AM
01-09	Stephens Adjusts Bio-Techne Price Target to $80 From $70, Maintains Overweight Rating	MT
01-06	Evercore ISI Downgrades Bio-Techne to In Line From Outperform, Adjusts PT to $62 From $68	MT
12-12	Deutsche Bank Adjusts Price Target on Bio-Techne to $72 From $66, Maintains Buy Rating	MT
12-12	Deutsche Bank Raises Price Target on Bio-Techne to $72 From $66, Keeps Buy Rating	MT
12-11	Bio-Techne Corporation Announces Strategic Collaboration Between One of Its Spatial Biology Brands, Lunaphore, and the Wyss Center for Bio and Neuroengineering	CI
12-11	Bio-Techne's Lunaphore Brand, Wyss Center Geneva Partner Over Automated Workflow Development	MT
12-09	Bio-Techne Launches the Enhanced Leo System Delivering Advanced Multiplexing and High-Throughput Protein Analysis	CI
12-09	Bio-Techne Corporation Presents at 53rd Annual Nasdaq Investor Conference, Dec-09-2025 09:30 AM
12-03	Bio-Techne Corporation Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 03:15 PM
12-02	Bio-Techne Corporation Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 08:20 AM
11-20	Bio-Techne Corporation Presents at Jefferies London Healthcare Conference 2025, Nov-20-2025 12:30 PM
11-20	Argus Adjusts Price Target on Bio-Techne to $68 From $65, Maintains Buy Rating	MT
11-18	Bio-Techne Corporation Presents at Stephens Annual Investment Conference 2025, Nov-18-2025 08:00 AM
11-18	Bio-Techne Licenses AI-Designed NovoBody Duo Molecules From Monod Bio	MT
11-18	Bio-Techne announces licensing agreement with Monod Bio	RE
11-11	Bio-Techne Corporation Presents at Stifel 2025 Healthcare Conference, Nov-11-2025 09:20 AM
11-10	Bio-Techne Corporation Presents at UBS Global Healthcare Conference 2025, Nov-10-2025 10:15 AM
11-06	Wells Fargo Adjusts Bio-Techne Price Target to $70 From $59, Maintains Overweight Rating	MT
11-06	Baird Adjusts Bio-Techne Price Target to $61 From $62, Maintains Neutral Rating	MT
11-06	Stephens Adjusts Bio-Techne Price Target to $70 From $65, Maintains Overweight Rating	MT
11-06	UBS Adjusts Price Target on Bio-Techne to $70 From $65, Maintains Buy Rating	MT
11-05	Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on May 6, 2025.	CI
11-05	Evercore ISI Adjusts Price Target on Bio-Techne to $68 From $72	MT
11-05	Bio-Techne Corporation, Q1 2026 Earnings Call, Nov 05, 2025